1999
DOI: 10.1038/8406
|View full text |Cite
|
Sign up to set email alerts
|

Neutralizing antibody-independent containment of immunodeficiency virus challenges by DNA priming and recombinant pox virus booster immunizations

Abstract: Eight different protocols were compared for their ability to raise protection against immunodeficiency virus challenges in rhesus macaques. The most promising containment of challenge infections was achieved by intradermal DNA priming followed by recombinant fowl pox virus booster immunizations. This containment did not require neutralizing antibody and was active for a series of challenges ending with a highly virulent virus with a primary isolate envelope heterologous to the immunizing strain.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

9
186
3
1

Year Published

2000
2000
2010
2010

Publication Types

Select...
5
5

Relationship

1
9

Authors

Journals

citations
Cited by 354 publications
(199 citation statements)
references
References 42 publications
9
186
3
1
Order By: Relevance
“…In addition to malaria, similar observations have been made in several experimental models, thereby confirming the potential of the heterologous prime-boost immunization regimen to enhance the specific immune response against multiple pathogens (reviewed by Zavala et al 2001). It is also important to point out that this increase in the frequency of specific CD8 T cells described initially in mice was recently confirmed in several types of non-human primates (Kent et al 1998, Robinson et al 1999, Hanke et al 1999, Allen et al 2000.…”
Section: Malaria Liver Stagesmentioning
confidence: 55%
“…In addition to malaria, similar observations have been made in several experimental models, thereby confirming the potential of the heterologous prime-boost immunization regimen to enhance the specific immune response against multiple pathogens (reviewed by Zavala et al 2001). It is also important to point out that this increase in the frequency of specific CD8 T cells described initially in mice was recently confirmed in several types of non-human primates (Kent et al 1998, Robinson et al 1999, Hanke et al 1999, Allen et al 2000.…”
Section: Malaria Liver Stagesmentioning
confidence: 55%
“…However, the relative importance of mobilizing each arm of the immune system and the means to induce each type of immunity are unclear. Although several successful passive immunization studies using neutralizing monoclonal antibodies in macaques strongly suggest that inducing broadly reactive neutralizing antibodies as part of any vaccine regimen would be beneficial [1][2][3][4][5], the levels and breadth of neutralizing antibodies induced by active vaccination have thus far proved insufficient to protect against infection [6][7][8]. It appears necessary that a vaccine must activate both cellular and humoral immune mechanisms.…”
Section: Introductionmentioning
confidence: 99%
“…DNA vaccines are generally effective at stimulating CD8 responses, whilst subunit vaccines are more effective at eliciting antibody responses (Barouch et al, 2000;Earl et al, 2001Earl et al, , 2002Patterson et al, 2004;Robinson, 1999). Combined-modality DNA prime-protein boost vaccination strategies have been evaluated in the past (Cristillo et al, 2006;Letvin et al, 1997;Mooij et al, 2004;Otten et al, 2005;Pal et al, 2005Pal et al, , 2006Robinson et al, 1999). As with single-modality envelope protein-based vaccines (Berman et al, 1990;Bruck et al, 1994;Girard et al, 1991;Hu et al, 1992;Mooij et al, 1998;Verschoor et al, 1999), protection against homologous, non-pathogenic simian-human immunodeficiency virus (SHIV) can be obtained (Letvin et al, 1997;Pal et al, 2006;Robinson et al, 1999).…”
Section: Introductionmentioning
confidence: 99%